PubMed:17177139 / 1721-1890 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T14","span":{"begin":0,"end":169},"obj":"Sentence"}],"text":"Moreover, a dominant inhibition of the wild-type TRbeta counterpart transactivation function was observed on both a positive (F2-TRE) and a negative (TSHalpha) promoter."}

{"project":"LitCoin-entities","denotations":[{"id":"3770","span":{"begin":49,"end":55},"obj":"GeneOrGeneProduct"},{"id":"3771","span":{"begin":150,"end":158},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A37","pred":"db_id","subj":"3770","obj":"NCBIGene:6955"},{"id":"A38","pred":"db_id","subj":"3771","obj":"NCBIGene:1081"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Moreover, a dominant inhibition of the wild-type TRbeta counterpart transactivation function was observed on both a positive (F2-TRE) and a negative (TSHalpha) promoter."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T34","span":{"begin":49,"end":55},"obj":"GeneOrGeneProduct"},{"id":"T35","span":{"begin":150,"end":158},"obj":"GeneOrGeneProduct"}],"text":"Moreover, a dominant inhibition of the wild-type TRbeta counterpart transactivation function was observed on both a positive (F2-TRE) and a negative (TSHalpha) promoter."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T58","span":{"begin":49,"end":55},"obj":"GeneOrGeneProduct"},{"id":"T59","span":{"begin":68,"end":83},"obj":"GeneOrGeneProduct"},{"id":"T60","span":{"begin":150,"end":158},"obj":"GeneOrGeneProduct"}],"text":"Moreover, a dominant inhibition of the wild-type TRbeta counterpart transactivation function was observed on both a positive (F2-TRE) and a negative (TSHalpha) promoter."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T10","span":{"begin":49,"end":55},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":150,"end":158},"obj":"GeneOrGeneProduct"}],"text":"Moreover, a dominant inhibition of the wild-type TRbeta counterpart transactivation function was observed on both a positive (F2-TRE) and a negative (TSHalpha) promoter."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T34780","span":{"begin":150,"end":158},"obj":"GeneOrGeneProduct"},{"id":"T61099","span":{"begin":49,"end":55},"obj":"GeneOrGeneProduct"}],"text":"Moreover, a dominant inhibition of the wild-type TRbeta counterpart transactivation function was observed on both a positive (F2-TRE) and a negative (TSHalpha) promoter."}